Director · Immunome Inc. · Immunome Inc. — Director Stock Option (right to buy)
Side
A
Value
—
Shares
9,897
Price
—
Executed
Jun 10, 2026
Disclosed
Jun 12, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 10 executedJun 12, 2026 disclosed
IMNM · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Immunome Inc. — Director Stock Option (right to buy)
Ticker
IMNM
Shares
9,897
Price per share
$0
Execution date (reported)
Jun 10, 2026
Owned after transaction
9,897 shares
Days from execution to publication
2
What this establishes
Boylan James P filed this Form 4 reporting a grant or award of IMNM on Jun 10, 2026. It became public on Jun 12, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Boylan James Pcik:0001953094
Issuer
Immunome Inc.cik:0001472012
Revision history · 0
No field has changed since this record was first ingested.
